March 20, 2017.
The Medicines Agency has just withdrawn two cosmetic products from sale. In question: two substances used in their composition are considered as medicinal products, and the manufacturing laboratory therefore uses them outside any legal framework.
A drug is hidden in a cosmetic product
Two anti-aging serums, marketed by the laboratory Promicea, have just been withdrawn from the market by the Medicines Agency (ANSM). In question : two substances that would make these creams not cosmetic products, but indeed drugs.
In a decision made official on March 13, the ANSM announced that it had suspended ” the manufacture, export, wholesale distribution and placing on the market free of charge or against payment, holding for sale […] products called Neostem Serum and Neostem Pocket Lift », As well as the withdrawal of these products.
The combination of two substances alerts the Medicines Agency
At the origin of this decision, the ANSM realized that the laboratory was using sodium alendronate and pravastatin, two substances that play a role in the synthesis of progerin, a protein involved in the aging of the skin. However, it is precisely this action that alerted the body, since this protein is a molecule known to be at the origin of a rare genetic disease, called Hutchinson-Gilford Syndrome, also known as progeria. .
The Medicines Agency therefore immediately concluded that ” pharmacological potential Of these two substances was proven and that the products of the Promicea laboratory therefore became incompatible with the status of claimed cosmetic product.
Sybille Latour
You will also like: Aging of the skin: what to do?
